Skip to main content

Social Media

Search

REQUEST E-APPLICATION FORM | 01244 746000 | Log in

Home Deepbridge

Main navigation

  • Products
    • Deepbridge Technology Growth EIS
    • Deepbridge Life Sciences EIS
    • Deepbridge Innovation SEIS
    • Deepbridge Life Sciences SEIS
    • Deepbridge Estate Planning Service
    • Deepbridge Syndicate
  • About
    • About Deepbridge
    • About EIS
    • About SEIS
    • Looking for funding?
    • E-Application Request Form
  • Our Investments
  • Our People
  • News & Events
    • News
    • Events
  • Contact

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.

Financial Adviser Confirmation

THIS CONTENT IS FOR PROFESSIONAL ADVISERS ONLY

Investments in unquoted companies carry high risks and investors could lose all funds invested. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. Investors are encouraged to take independent legal, tax and financial advice before considering an investment.

By clicking below, you confirm that you are an FCA authorised firm or individual and agree to be directed to our website, which is for FCA authorised firms and individuals only. Persons who do not meet this classification should leave this page.

If you are not a professional financial adviser, please contact the Deepbridge Investor Relations Team on 01244 746000 or by email at enquiries@deepbridgecapital.com.

Back
  1. News
  2. Archive
  3. Archive

August 2018

Glyconics sign hardware partner agreement

11th August 2018

 

Deepbridge are pleased to report that Glyconics, which is part of the Deepbridge Life Sciences SEIS portfolio, have signed a hardware partner agreement with Spectrolytic, a leading developer in infared (IR) spectrometers.

  • Read more about Glyconics sign hardware partner agreement

Almac and Elasmogen receive £2m grant

24th August 2018

The biopharmaceutical company Almac Discovery - part of the contract development and manufacturing organisation (CDMO) Almac Group -and Elasmogen, a University of Aberdeen spin-out firm and part of the Deepbridge Life Sciences EIS portfolio, have been awarded a £2m grant from Innovate UK.

  • Read more about Almac and Elasmogen receive £2m grant

Important Information

Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.

What are the key risks?

1. You could lose all the money you invest

  • If the business you invest in fails, you are likely to lose 100% of the money you invested. Most start-up businesses fail.

2. You are unlikely to be protected if something goes wrong

  • Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker here. [https://www.fscs.org.uk/check/investment-protection-checker/]
  • Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated firm, FOS may be able to consider it. Learn more about FOS protection here. [https://www.financial-ombudsman.org.uk/consumers]

3. You won’t get your money back quickly

  • Even if the business you invest in is successful, it may take several years to get your money back. You are unlikely to be able to sell your investment early.
  • The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common.
  • If you are investing in a start-up business, you should not expect to get your money back through dividends. Start-up businesses rarely pay these.

4. Don’t put all your eggs in one basket

  • Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well.
  • A good rule of thumb is not to invest more than 10% of your money in high-risk investments.  [https://www.fca.org.uk/investsmart/5-questions-ask-you-invest]

5. The value of your investment can be reduced

  • The percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows. Most start-up businesses issue multiple rounds of shares.
  • These new shares could have additional rights that your shares don’t have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.

If you are interested in learning more about how to protect yourself, visit the FCA’s website here. [https://www.fca.org.uk/investsmart]

Social Media

IMPORTANT NOTICE

This website is a financial promotion approved by Deepbridge Capital LLP for the purposes of section 21 Financial Services and Markets Act 2000 relating to the communication of invitations or inducements to engage in investment activity.

Deepbridge Capital LLP is a limited liability partnership registered in England & Wales. Registered No. OC356449. Registered Office: Deepbridge House, Honeycomb East, Chester Business Park, Chester CH4 9QN. Deepbridge Capital LLP is authorised and regulated by the Financial Conduct Authority (FRN: 563366).

Member of:

 

Footer menu

  • Privacy & Cookies Policy
  • Complaints Policy